Medicare Enrolled
Dr. Magda Melchert, MD
Hematology · Brandon, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Melchert from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Melchert? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Melchert
Dr. Magda Melchert is a hematology in Brandon, FL, with 19 years in practice. Based on federal Medicare data, Dr. Melchert performed 158,567 Medicare services across 4,051 unique beneficiaries.
Between the years covered by Open Payments, Dr. Melchert received a total of $5,191 from 64 pharmaceutical and/or device companies across 289 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Melchert is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 32% volume in FL$ $5,191 industry payments
Medicare Practice Summary
Medicare Utilization ↗158,567
Medicare services
Top 32% in FL for hematology
4,051
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8,346 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 54,570 | $0 | $4 |
| Iron sucrose injection (Venofer) | 30,000 | $0 | $5 |
| Contrast dye for imaging (iodine-based) | 14,015 | $0 | $1 |
| Filgrastim injection (Zarxio) for white blood cells | 10,320 | $0 | $2 |
| Anti-nausea injection (aprepitant) | 9,490 | $1 | $5 |
| Paclitaxel chemotherapy injection | 9,303 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 7,200 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia | 6,120 | $6 | $23 |
| Injection, atropine sulfate, 0.01 mg | 2,760 | $0 | $1 |
| Dexamethasone injection (steroid) | 2,406 | $0 | $3 |
| Complete blood count (CBC) with differential | 1,804 | $8 | $29 |
| Iron infusion (Monoferric) | 1,800 | $16 | $57 |
| Blood draw (venipuncture) | 1,690 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,180 | $1 | $28 |
| Office visit, established patient (30-39 min) | 683 | $93 | $339 |
| Anti-nausea injection (ondansetron/Zofran) | 680 | $0 | $9 |
| Drug injection, under skin or into muscle | 657 | $10 | $69 |
| Injection of additional new drug or substance into vein | 424 | $11 | $61 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 381 | $48 | $189 |
| Administration of chemotherapy into vein, 1 hour or less | 331 | $95 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 307 | $21 | $84 |
| Office visit, established patient (20-29 min) | 290 | $63 | $239 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 277 | $1 | $6 |
| Ct scan of chest with contrast | 139 | $48 | $344 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 139 | $17 | $59 |
| Injection, zoledronic acid, 1 mg | 133 | $7 | $69 |
| Injection, diphenhydramine hcl, up to 50 mg | 132 | $1 | $3 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 124 | $399 | $680 |
| Administration of chemotherapy into vein, each additional hour | 116 | $21 | $79 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 115 | $1,096 | $3,706 |
| CT scan of abdomen and pelvis with contrast | 113 | $167 | $550 |
| Administration of additional new drug or substance into vein, 1 hour or less | 110 | $47 | $178 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 95 | $16 | $56 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 95 | $3 | $11 |
| Infusion into a vein for hydration, each additional hour | 81 | $10 | $42 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 72 | $23 | $89 |
| Infusion, normal saline solution , 1000 cc | 63 | $2 | $7 |
| Red blood count, automated test | 62 | $4 | $10 |
| Prothrombin time test (blood clotting) | 62 | $4 | $15 |
| New patient office visit (30-44 min) | 43 | $79 | $298 |
| New patient office visit (45-59 min) | 34 | $127 | $453 |
| CT scan of chest, without contrast | 32 | $52 | $350 |
| Automated urinalysis | 32 | $2 | $8 |
| Office visit, established patient, complex (40-54 min) | 29 | $140 | $474 |
| Infusion into a vein for hydration, 31-60 minutes | 24 | $24 | $156 |
| Injection of drug or substance into vein | 20 | $25 | $156 |
| Nuclear medicine study whole body with ct scan | 14 | $1,087 | $3,706 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
36.1% high complexity
60.6% medium
3.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,191
Total received (2018-2024)
Avg $742/year across 7 years
Bottom 41% in FL for hematology
64
Companies
289
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,179 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,058
2023$1,399
2022$583
2021$162
2020$224
2019$1,006
2018$758
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$628
Janssen Biotech, Inc.
$487
PFIZER INC.
$309
Lilly USA, LLC
$261
Novartis Pharmaceuticals Corporation
$245
Celgene Corporation
$187
Genentech USA, Inc.
$172
Daiichi Sankyo Inc.
$163
Amgen Inc.
$148
Merck Sharp & Dohme LLC
$146
Merck Sharp & Dohme Corporation
$146
GlaxoSmithKline, LLC.
$119
AstraZeneca Pharmaceuticals LP
$112
Sirtex Medical Inc
$104
Seagen Inc.
$103
Gilead Sciences, Inc.
$93
Boston Scientific Corporation
$87
Myriad Genetic Laboratories, Inc.
$78
ARRAY BIOPHARMA INC
$76
TESARO, Inc.
$73
Regeneron Healthcare Solutions, Inc.
$72
Takeda Pharmaceuticals U.S.A., Inc.
$67
BeiGene USA, Inc.
$61
EISAI INC.
$59
Inari Medical, Inc.
$58
Bayer HealthCare Pharmaceuticals Inc.
$56
SpringWorks Therapeutics, Inc.
$55
Exelixis Inc.
$54
Aadi Bioscience, Inc.
$47
Alexion Pharmaceuticals, Inc.
$47
PharmaEssentia USA Corporation
$46
Mirati Therapeutics, Inc.
$42
Ipsen Biopharmaceuticals, Inc
$40
Boehringer Ingelheim Pharmaceuticals, Inc.
$38
GE HealthCare
$36
CSL Behring
$36
Taiho Oncology, Inc.
$36
SOBI, INC
$35
NanoString Technologies, Inc.
$35
GENZYME CORPORATION
$33
Incyte Corporation
$33
TAIHO ONCOLOGY, INC.
$29
ImmunoGen, Inc.
$29
Astellas Pharma US Inc
$29
Eisai Inc.
$25
Adaptive Biotechnologies Corporation
$24
Bayer Healthcare Pharmaceuticals Inc.
$24
TerSera Therapeutics LLC
$23
JAZZ PHARMACEUTICALS INC.
$22
Janssen Pharmaceuticals, Inc
$21
Spectrum Pharmaceuticals Inc.
$21
SERVIER PHARMACEUTICALS LLC
$21
Heron Therapeutics, Inc.
$20
Pharmacyclics LLC, An AbbVie Company
$20
AVEO Pharmaceuticals, Inc.
$19
ABBVIE INC.
$18
G1 Therapeutics, Inc.
$18
Sobi, Inc
$17
Array BioPharma Inc.
$17
EMD Serono, Inc.
$15
INSYS Therapeutics Inc
$14
Helsinn Therapeutics (U.S.), Inc.
$14
Agios Pharmaceuticals, Inc.
$13
AbbVie, Inc.
$11
Top 3 companies account for 27.4% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ALUNBRIG · Abraxane · Afstyla · Alecensa · Aliqopa · Avastin · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABOMETYX · CALQUENCE · CINVANTI · COSELA · CYRAMZA · Cabometyx · Creon · DARZALEX · DOPTELET · Doptelet · ELIQUIS · EMEND · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · Elahere · Enhertu · Erleada · FLOWTRIEVER CATHETER · FOTIVDA · FRUZAQLA · Fabhalta · Folotyn · Fyarro · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · INJECTAFER · INREBIC · Idelvion · Imbruvica · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MONJUVI · MVASI · MYRISK · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROSIGNA ASSAY · Perjeta · Pomalyst · REBLOZYL · Revlimid · S · SANDOSTATIN · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · Stivarga · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TUKYSA · Tibsovo · Trodelvy · VENCLEXTA · VERZENIO · VONJO · Venclexta · WaveWriter Alpha Prime 16 · XALKORI · XARELTO · XGEVA · XTANDI · Xofigo · Xtandi · ZEJULA · ZEPZELCA · ZOLADEX · ZYKADIA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $3 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
30
Per 100K population
2.0
County median income
$75,011
Nearest hospital
HCA FLORIDA BRANDON HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Melchert is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Melchert experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Melchert performed 54,570 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Melchert receive payments from pharmaceutical companies?
Yes. Dr. Melchert received a total of $5,191 from 64 companies across 289 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Melchert's costs compare to other hematologys in Brandon?
Dr. Melchert's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Melchert) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Brandon
Browse hematologys in Brandon ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology